Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 45 of 45 entries
Sorted by: Best Match Show Resources per page
Bariatric surgery as metabolic surgery for diabetic patients.

Current pharmaceutical design

Kalyvas AV, Vlachos K, Abu-Amara M, Sampalis JS, Glantzounis G.
PMID: 24040876
Curr Pharm Des. 2014;20(22):3631-46. doi: 10.2174/13816128113196660672.

The recent increase in the prevalence of obesity seems to be responsible for the increase in T2 Diabetes Mellitus (T2DM). At present around 50 % of T2DM patients are obese and this percentage appears set to increase in the...

Cite
Kalyvas AV, Vlachos K, Abu-Amara M, et al. Bariatric surgery as metabolic surgery for diabetic patients. Curr Pharm Des. 2014;20(22):3631-46doi: 10.2174/13816128113196660672.
Kalyvas, A. V., Vlachos, K., Abu-Amara, M., Sampalis, J. S., & Glantzounis, G. (2014). Bariatric surgery as metabolic surgery for diabetic patients. Current pharmaceutical design, 20(22), 3631-46. https://doi.org/10.2174/13816128113196660672
Kalyvas, Aristotelis V, et al. "Bariatric surgery as metabolic surgery for diabetic patients." Current pharmaceutical design vol. 20,22 (2014): 3631-46. doi: https://doi.org/10.2174/13816128113196660672
Kalyvas AV, Vlachos K, Abu-Amara M, Sampalis JS, Glantzounis G. Bariatric surgery as metabolic surgery for diabetic patients. Curr Pharm Des. 2014;20(22):3631-46. doi: 10.2174/13816128113196660672. PMID: 24040876.
Copy Download .nbib Format: NLM
Study busts myth of "metabolically healthy" obesity.

BMJ (Clinical research ed.)

Mayor S.
PMID: 24319268
BMJ. 2013 Dec 06;347:f7324. doi: 10.1136/bmj.f7324.

No abstract available.

Cite
Mayor S. Study busts myth of "metabolically healthy" obesity. BMJ. 2013;347:f7324doi: 10.1136/bmj.f7324.
Mayor, S. (2013). Study busts myth of "metabolically healthy" obesity. BMJ (Clinical research ed.), 347f7324. https://doi.org/10.1136/bmj.f7324
Mayor, Susan. "Study busts myth of "metabolically healthy" obesity." BMJ (Clinical research ed.) vol. 347 (2013): f7324. doi: https://doi.org/10.1136/bmj.f7324
Mayor S. Study busts myth of "metabolically healthy" obesity. BMJ. 2013 Dec 06;347:f7324. doi: 10.1136/bmj.f7324. PMID: 24319268.
Copy Download .nbib Format: NLM
Genomics and Metabolomics in Obesity and Type 2 Diabetes.

Journal of diabetes research

Kretowski A, Ruperez FJ, Ciborowski M.
PMID: 27314051
J Diabetes Res. 2016;2016:9415645. doi: 10.1155/2016/9415645. Epub 2016 May 25.

No abstract available.

Cite
Kretowski A, Ruperez FJ, Ciborowski M. Genomics and Metabolomics in Obesity and Type 2 Diabetes. J Diabetes Res. 2016;2016:9415645doi: 10.1155/2016/9415645.
Kretowski, A., Ruperez, F. J., & Ciborowski, M. (2016). Genomics and Metabolomics in Obesity and Type 2 Diabetes. Journal of diabetes research, 20169415645. https://doi.org/10.1155/2016/9415645
Kretowski, Adam, et al. "Genomics and Metabolomics in Obesity and Type 2 Diabetes." Journal of diabetes research vol. 2016 (2016): 9415645. doi: https://doi.org/10.1155/2016/9415645
Kretowski A, Ruperez FJ, Ciborowski M. Genomics and Metabolomics in Obesity and Type 2 Diabetes. J Diabetes Res. 2016;2016:9415645. doi: 10.1155/2016/9415645. Epub 2016 May 25. PMID: 27314051; PMCID: PMC4897675.
Copy Download .nbib Format: NLM
Metabolically healthy but obese individuals.

Lancet (London, England)

Karelis AD.
PMID: 18929889
Lancet. 2008 Oct 11;372(9646):1281-3. doi: 10.1016/S0140-6736(08)61531-7.

No abstract available.

Cite
Karelis AD. Metabolically healthy but obese individuals. Lancet. 2008;372(9646):1281-3doi: 10.1016/S0140-6736(08)61531-7.
Karelis, A. D. (2008). Metabolically healthy but obese individuals. Lancet (London, England), 372(9646), 1281-3. https://doi.org/10.1016/S0140-6736(08)61531-7
Karelis, Antony D. "Metabolically healthy but obese individuals." Lancet (London, England) vol. 372,9646 (2008): 1281-3. doi: https://doi.org/10.1016/S0140-6736(08)61531-7
Karelis AD. Metabolically healthy but obese individuals. Lancet. 2008 Oct 11;372(9646):1281-3. doi: 10.1016/S0140-6736(08)61531-7. PMID: 18929889.
Copy Download .nbib Format: NLM
[Positive effects of physical exercise on reducing the relationship between subcutaneous abdominal fat and morbility risk].

Nutricion hospitalaria

González Calvo G, Hernández Sánchez S, Pozo Rosado P, García López D.
PMID: 22470011
Nutr Hosp. 2011 Jul-Aug;26(4):685-91. doi: 10.1590/S0212-16112011000400004.

INTRODUCTION: The consequences related to the accumulation of abdominal fat above healthy levels create a considerable organic damage. Among the physiological consequences we can highlight heart diseases, hypertension, type-2 diabetes, obesity and metabolic syndrome, which drastically reduce life expectancy...

Cite
González Calvo G, Hernández Sánchez S, Pozo Rosado P, et al. Asociación entre tejido graso abdominal y riesgo de morbilidad: efectos positivos del ejercicio físico en la reducción de esta tendencia. [Positive effects of physical exercise on reducing the relationship between subcutaneous abdominal fat and morbility risk]. Nutr Hosp. 2011;26(4):685-91doi: 10.1590/S0212-16112011000400004.
González Calvo, G., Hernández Sánchez, S., Pozo Rosado, P., & García López, D. (2011). Asociación entre tejido graso abdominal y riesgo de morbilidad: efectos positivos del ejercicio físico en la reducción de esta tendencia. [Positive effects of physical exercise on reducing the relationship between subcutaneous abdominal fat and morbility risk]. Nutricion hospitalaria, 26(4), 685-91. https://doi.org/10.1590/S0212-16112011000400004
González Calvo, G, et al. "Asociación entre tejido graso abdominal y riesgo de morbilidad: efectos positivos del ejercicio físico en la reducción de esta tendencia." [Positive effects of physical exercise on reducing the relationship between subcutaneous abdominal fat and morbility risk]. Nutricion hospitalaria vol. 26,4 (2011): 685-91. doi: https://doi.org/10.1590/S0212-16112011000400004
González Calvo G, Hernández Sánchez S, Pozo Rosado P, García López D. Asociación entre tejido graso abdominal y riesgo de morbilidad: efectos positivos del ejercicio físico en la reducción de esta tendencia. [Positive effects of physical exercise on reducing the relationship between subcutaneous abdominal fat and morbility risk]. Nutr Hosp. 2011 Jul-Aug;26(4):685-91. doi: 10.1590/S0212-16112011000400004. Spanish. PMID: 22470011.
Copy Download .nbib Format: NLM
[Which dosing for medications in obese children?].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Bardin C.
PMID: 19541238
Arch Pediatr. 2009 Jun;16(6):965-7. doi: 10.1016/S0929-693X(09)74220-4.

No abstract available.

Cite
Bardin C. Quelle posologie de médicaments chez l'enfant obèse? [Which dosing for medications in obese children?]. Arch Pediatr. 2009;16(6):965-7doi: 10.1016/S0929-693X(09)74220-4.
Bardin, C. (2009). Quelle posologie de médicaments chez l'enfant obèse? [Which dosing for medications in obese children?]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 16(6), 965-7. https://doi.org/10.1016/S0929-693X(09)74220-4
Bardin, C. "Quelle posologie de médicaments chez l'enfant obèse?" [Which dosing for medications in obese children?]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 16,6 (2009): 965-7. doi: https://doi.org/10.1016/S0929-693X(09)74220-4
Bardin C. Quelle posologie de médicaments chez l'enfant obèse? [Which dosing for medications in obese children?]. Arch Pediatr. 2009 Jun;16(6):965-7. doi: 10.1016/S0929-693X(09)74220-4. French. PMID: 19541238.
Copy Download .nbib Format: NLM
Obesity: common symptom of diverse gene-based metabolic dysregulations. Proceedings of a symposium. Little Rock, Arkansas, March 4, 1997.

The Journal of nutrition

[No authors listed]
PMID: 9278572
J Nutr. 1997 Sep;127(9):1871S-1922S. doi: 10.1093/jn/127.9.1871S.

No abstract available.

Cite
Obesity: common symptom of diverse gene-based metabolic dysregulations. Proceedings of a symposium. Little Rock, Arkansas, March 4, 1997. J Nutr. 1997;127(9):1871S-1922Sdoi: 10.1093/jn/127.9.1871S.
(1997). Obesity: common symptom of diverse gene-based metabolic dysregulations. Proceedings of a symposium. Little Rock, Arkansas, March 4, 1997. The Journal of nutrition, 127(9), 1871S-1922S. https://doi.org/10.1093/jn/127.9.1871S
"Obesity: common symptom of diverse gene-based metabolic dysregulations. Proceedings of a symposium. Little Rock, Arkansas, March 4, 1997." The Journal of nutrition vol. 127,9 (1997): 1871S-1922S. doi: https://doi.org/10.1093/jn/127.9.1871S
Obesity: common symptom of diverse gene-based metabolic dysregulations. Proceedings of a symposium. Little Rock, Arkansas, March 4, 1997. J Nutr. 1997 Sep;127(9):1871S-1922S. doi: 10.1093/jn/127.9.1871S. PMID: 9278572.
Copy Download .nbib Format: NLM
The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery.

Canadian journal of diabetes

Anhê FF, Varin TV, Schertzer JD, Marette A.
PMID: 28552651
Can J Diabetes. 2017 Aug;41(4):439-447. doi: 10.1016/j.jcjd.2017.02.002. Epub 2017 May 25.

Bariatric surgery is based on major anatomic rearrangements in the gastrointestinal tract that coincide with functional and taxonomic changes in gut microbial communities. These alterations in gut anatomy and in the microbiota are associated with early resolution of obesity-related...

Cite
Anhê FF, Varin TV, Schertzer JD, et al. The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery. Can J Diabetes. 2017;41(4):439-447doi: 10.1016/j.jcjd.2017.02.002.
Anhê, F. F., Varin, T. V., Schertzer, J. D., & Marette, A. (2017). The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery. Canadian journal of diabetes, 41(4), 439-447. https://doi.org/10.1016/j.jcjd.2017.02.002
Anhê, Fernando F, et al. "The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery." Canadian journal of diabetes vol. 41,4 (2017): 439-447. doi: https://doi.org/10.1016/j.jcjd.2017.02.002
Anhê FF, Varin TV, Schertzer JD, Marette A. The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery. Can J Diabetes. 2017 Aug;41(4):439-447. doi: 10.1016/j.jcjd.2017.02.002. Epub 2017 May 25. PMID: 28552651.
Copy Download .nbib Format: NLM
The human gut microbiota: Metabolism and perspective in obesity.

Gut microbes

Gomes AC, Hoffmann C, Mota JF.
PMID: 29667480
Gut Microbes. 2018 Jul 04;9(4):308-325. doi: 10.1080/19490976.2018.1465157. Epub 2018 May 24.

The gut microbiota has been recognized as an important factor in the development of metabolic diseases such as obesity and is considered an endocrine organ involved in the maintenance of energy homeostasis and host immunity. Dysbiosis can change the...

Cite
Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes. 2018;9(4):308-325doi: 10.1080/19490976.2018.1465157.
Gomes, A. C., Hoffmann, C., & Mota, J. F. (2018). The human gut microbiota: Metabolism and perspective in obesity. Gut microbes, 9(4), 308-325. https://doi.org/10.1080/19490976.2018.1465157
Gomes, Aline Corado, et al. "The human gut microbiota: Metabolism and perspective in obesity." Gut microbes vol. 9,4 (2018): 308-325. doi: https://doi.org/10.1080/19490976.2018.1465157
Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes. 2018 Jul 04;9(4):308-325. doi: 10.1080/19490976.2018.1465157. Epub 2018 May 24. PMID: 29667480; PMCID: PMC6219651.
Copy Download .nbib Format: NLM
Showing 37 to 45 of 45 entries